Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
Dale M, Fitzgerald MP, Liu Z, Meisinger T, Karpisek A, Purcell LN, Carson JS, Harding P, Lang H, Koutakis P, Suh M, Batra R, Mietus CJ, Casale G, Pipinos I, Baxter BT, Xiong W. Dale M, et al. Among authors: harding p. PLoS One. 2018 Jul 16;13(7):e0200985. doi: 10.1371/journal.pone.0200985. eCollection 2018. PLoS One. 2018. PMID: 30011334 Free PMC article.
Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
Dale M, Fitzgerald MP, Liu Z, Meisinger T, Karpisek A, Purcell LN, Carson JS, Harding P, Lang H, Koutakis P, Suh M, Batra R, Mietus CJ, Casale G, Pipinos I, Baxter BT, Xiong W. Dale M, et al. Among authors: harding p. PLoS One. 2017 Oct 17;12(10):e0186603. doi: 10.1371/journal.pone.0186603. eCollection 2017. PLoS One. 2017. PMID: 29040313 Free PMC article.
Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
Jespersen K, Li C, Batra R, Stephenson CA, Harding P, Sestak K, Foley RT, Greene H, Meisinger T, Cook JR, Baxter BT, Xiong W. Jespersen K, et al. Among authors: harding p. J Immunol Res. 2022 Feb 15;2022:7538649. doi: 10.1155/2022/7538649. eCollection 2022. J Immunol Res. 2022. PMID: 35211631 Free PMC article.
Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Agwu AL, Warshaw MG, McFarland EJ, Siberry GK, Melvin AJ, Wiznia AA, Fairlie L, Boyd S, Harding P, Spiegel HML, Abrams EJ, Carey VJ; P1094 Study Team. Agwu AL, et al. Among authors: harding p. PLoS One. 2017 Jun 12;12(6):e0178075. doi: 10.1371/journal.pone.0178075. eCollection 2017. PLoS One. 2017. PMID: 28604824 Free PMC article. Clinical Trial.
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, Safrit JT, Mofenson LM, Mathieson B, Valentine ME, Perlowski C, Smith B, Hazra R, Purdue L, Muresan P, Harding PA, Mbengeranwa T, Robinson LG, Wiznia A, Theron G, Lin B, Bailer RT, Mascola JR, Graham BS; IMPAACT P1112 team. Cunningham CK, et al. Among authors: harding pa. J Infect Dis. 2020 Jul 23;222(4):628-636. doi: 10.1093/infdis/jiz532. J Infect Dis. 2020. PMID: 31681963 Free PMC article. Clinical Trial.
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
McFarland EJ, Cunningham CK, Muresan P, Capparelli EV, Perlowski C, Morgan P, Smith B, Hazra R, Purdue L, Harding PA, Theron G, Mujuru H, Agwu A, Purswani M, Rathore MH, Flach B, Taylor A, Lin BC, McDermott AB, Mascola JR, Graham BS; International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1112 Team. McFarland EJ, et al. Among authors: harding pa. J Infect Dis. 2021 Dec 1;224(11):1916-1924. doi: 10.1093/infdis/jiab229. J Infect Dis. 2021. PMID: 34009371 Free PMC article.
386 results